CASE STUDIES
See how Precision Oncology Consulting partners with companies to develop strategic projects, leading to growth and improved positioning for long-term success. Real-world examples illustrate the impact of this collaborative approach.
Navigating the Global NGS Oncology Market
Strategic market analysis of the global next-generation sequencing (NGS) landscape across the US, Europe, and Asia, identifying key providers, regulatory developments, and adoption trends shaping precision oncology
Analysis of Biomarker Reimbursement in Oncology
Comprehensive analysis of biomarker testing reimbursement pathways across major European markets, providing strategic insights into payer requirements, evidence expectations, and market access challenges.
Molecular Diagnostic Reimbursement: A Value Dossier
Development of a payer-focused value dossier for a novel molecular diagnostic, combining epidemiology analysis, clinical evidence generation, and economic impact assessment to support reimbursement.
Comprehensive Genomic Profiling: A Value Dossier
Evidence-based reimbursement strategy for comprehensive genomic profiling (CGP), demonstrating clinical utility, economic value, and the role of multi-gene testing in advancing precision oncology.
